Data as of Q4 2025 (Dec 31, 2025)
โณ
Showing Q4 2024 data
Lunate Holding RSC Ltd's Q4 2025 filing not yet available. Expected by Feb 14, 2026.

Lunate Holding RSC Ltd

โ€ขCIK: 2009522โ€ขFiling: Q4 2024

Lunate Holding RSC Ltd manages $211M across a concentrated portfolio of four positions. The fund exhibits significant conviction in its top holdings, led by RVMD, which represents the largest allocation at $96.1M. Further substantial exposure is maintained in AMP ($57.2M), LINE ($35.1M), and NMRA ($22.5M). This structure suggests a highly focused, high-conviction investment mandate within its current market positioning.

Total AUM
$210.9M
QoQ Performance
N/A
Positions
4
Top 10 Concentration
100.0%
Latest Filing
Q4 2024

Top Holdings Allocation

RVMD
BIRK
LINE
NMRA
RVMD45.5%
BIRKENSTOCK27.1%
LINE16.7%
NMRA10.7%

๐Ÿ“ˆ Biggest Buys

RVMD
REVOLUTION MEDICINES INC
NEW
45.5% of portfolio
โ€”
BIRKENSTOCK HOLDING PLC
NEW
27.1% of portfolio
LINE
LINEAGE INC
NEW
16.7% of portfolio
NMRA
NEUMORA THERAPEUTICS INC.
NEW
10.7% of portfolio

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other100.0%